News & Trends - MedTech & Diagnostics
Portable brain scanner to bridge gap in stroke care between regional and metro
MedTech & Diagnostics News: The Australian medical device company, EMVision, has unveiled its First Responder Proof of Concept device, designed for deployment via road and air ambulances.
Scott Kirkland, CEO and Co-Founder at EMVision, said “An abiding certainty in stroke is that the fastest possible diagnosis and treatment will result in better outcomes, such as less disability, for patients.
“There is a huge unmet clinical need for a portable, cost-effective, and easy-to-deploy device that can distinguish whether a suspected ischaemic or haemorrhagic stroke has occurred. We are excited by the opportunity to help revolutionise prehospital stroke care and make a substantial positive impact on one of the major causes of global disability.”
The backpack-sized scanner weighs less than about 10 kilograms and will enable paramedics to scan and send images to stroke experts from the site of a suspected stroke.
With more than 100 strokes estimated to occur in Australia every day, the technology has the potential to drastically improve the speed of diagnosis and treatment, particularly in settings where traditional imaging modalities like CT and MRI are not readily available.
The First Responder device leverages the underlying innovation from EMVision’s emu™ brain scanner. The emu is a trolley-mounted device, targeted for use in intensive care units, stroke and neurology wards, and rural emergency departments, involving a simple cap placed on the patient’s head for quick scans and timely stroke and stroke subtype assessment. It couples safe, ultra-high frequency radio signals with powerful artificial intelligence to produce rapid insights at the patient’s bedside.
Professor Geoffrey Donnan, co-Chair of the Australian Stroke Alliance, emphasised the importance of the identification of blood as a prerequisite for therapeutic decision-making in acute stroke management.
“Early results are encouraging and the lightweight nature of the EMVision device is likely to make it useful in the prehospital stroke environment,” he said.
This First Responder unit is a second-generation device with a lighter and miniaturised design, with expanded antenna coverage designed to offer full brain coverage in a single scan. It will now be the subject of a series of studies and developments to ensure its usability, reliability, and functionality to support the regulatory approval pathway. Both devices can be operated at the point-of-care by any healthcare professional with minimal training.
Dr Lisa Murphy, CEO of the Stroke Foundation, commented “This is an exciting step forward in reducing the gap that exists between regional and metropolitan stroke care. Every Australian patient deserves access to fast treatment and quality stroke care, regardless of their postcode. Access to fast diagnosis and treatment of stroke can be the difference between life or death and recovering well or living with severe disability, so technology like this is critical in improving outcomes for survivors of stroke.”
Professor Stephen Davis, co-Chair of the Australian Stroke Alliance, stated “We are looking forward to the validation of the sensitivity and specificity for detection of blood in hyperacute stroke patients using the EMVision device, against CT scanning, the current gold standard in stroke management. The weight of the device – about 10 kilograms – compares extremely favourably to a conventional mobile CT scanner of at least 500 kilograms.”
In reimagining healthcare, Health Industry HubTM is the ONLY one-stop-hub uniting the diversity of Pharma, MedTech, Diagnostics & Biotech sectors to inspire meaningful change. The exclusive leadership and influencer podcasts and vodcasts offer unparalleled insights and add immense value to our breaking news coverage.
The Health Industry HubTM content is copyright protected. Access is available under individual user licenses. Please click here to subscribe and visit T&Cs here.
News & Trends - MedTech & Diagnostics
Government faces scrutiny for inaction in private hospital sector despite Health Check warnings
Shadow Health Minister Senator Anne Ruston questioned the Department of Health’s commitment to addressing critical issues in the private hospital […]
MoreNews & Trends - MedTech & Diagnostics
Australia lags behind in funding pharmacogenomic testing: Pathologists urge action
Diagnostics & MedTech News: The call for urgent action to improve access to pharmacogenomic testing across Australia comes as demand […]
MoreNews & Trends - Pharmaceuticals
Australia’s first Cholesterol Awareness Week launched to tackle nation’s ‘silent disease’
Pharma News: Leading heart charities have come together to launch the nation’s first Cholesterol Awareness Week (11-17 November), aiming to […]
More